Results 31 to 40 of about 84,619 (287)
Cross-Protective Immunity against Heterologous Streptococcus pneumoniae [PDF]
Chimalapati et al. recently reported that infection with conditionally virulent Streptococcus pneumoniae Δ pab strains (containing a deletion of the gene encoding para -aminobenzoic acid synthetase) induced an effective antibody response to conserved protein antigens of S. pneumoniae ([1][1]).
Leen, Moens +3 more
openaire +2 more sources
With the emergence of novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Variants of Concern (VOCs), vaccination studies that elucidate the efficiency and effectiveness of a vaccination campaign are critical to assess the durability and ...
Natalie Heinen +30 more
doaj +1 more source
Defective interfering virus protects elderly mice from influenza [PDF]
Background: We have identified and characterised a defective-interfering (DI) influenza A virus particles containing a highly deleted segment 1 RNA that has broad-spectrum antiviral activity.
Scott, P. D. (Paul D.) +4 more
core +3 more sources
Pathogenic epitopes, heterologous immunity and vaccine design [PDF]
Substantial research has been directed towards the development of a new generation of vaccines that are based on the inclusion of immunogenic epitopes in recombinant vectors. Here we examine the evidence that under certain conditions immunogenic epitopes can do more harm than good and might therefore be considered pathogenic.
Welsh, Raymond M., Fujinami, Robert S.
openaire +2 more sources
Heterologous prime-boost vaccination with H3N2 influenza viruses of swine favors cross-clade antibody responses and protection [PDF]
The emergence of multiple novel lineages of H1 and H3 influenza A viruses in swine has confounded control by inactivated vaccines. Because of substantial genetic and geographic heterogeneity among circulating swine influenza viruses, one vaccine strain ...
Claes, Gerwin +8 more
core +2 more sources
Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections
The central paradigm of vaccination is to generate resistance to infection by a specific pathogen when the vacinee is re-exposed to that pathogen. This paradigm is based on two fundamental characteristics of the adaptive immune system, specificity and ...
Babita Agrawal
doaj +1 more source
Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity
Since SARS-CoV-2 was first reported in late 2019, multiple variations of the original virus have emerged. Each variant harbors accumulations of mutations, particularly within the spike glycoprotein, that are associated with increased viral ...
Saina Beitari +6 more
doaj +1 more source
BackgroundWith the widespread transmission of the Omicron SARS-CoV-2 variant, reinfections have become increasingly common. Here, we explored the role of immunity, primary infection severity, and variant predominance in the risk of reinfection and severe
José Antonio Montes-González +11 more
doaj +1 more source
Heterologous immunity meets tissue-specific training [PDF]
Tracy Hussell describes a 2003 study by Chen et al. that pioneered the concept of heterologous immunity.
openaire +2 more sources
Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase [PDF]
SUMMARY Anti-neutrophil cytoplasmic antibodies (ANCA), including anti-myeloperoxidase (MPO) antibodies, are associated with pauci-immune necrotizing small vessel vasculitis or glomerulonephritis, 1n order to substantiate a pathogenic role for ANCA, an animal model of pauci-immune ANCA-induced glomerulonephritis or vasculitis is required.
J J, Yang, J C, Jennette, R J, Falk
openaire +2 more sources

